Skip to main content

Advertisement

Fig. 2 | BMC Cancer

Fig. 2

From: A multiple breast cancer stem cell model to predict recurrence of T1–3, N0 breast cancer

Fig. 2

Establishment and Validation of RRS of early-stage BIDC patients, a Kaplan-Meier analysis for RFS of early-stage BIDC patients in training group. b Kaplan-Meier analysis for RFS of early-stage BIDC patients in testing group. c The distribution of the RRS, patients’ relapse status and biomarker expression in training group. d The distribution of the RRS, patients’ relapse status and biomarker expression in the testing group. (We conducted 10 times; Fig. 2 is only one example of them)

Back to article page